Polyphenols as adjunctive treatments in psychiatric and neurodegenerative disorders: Efficacy, mechanisms of action, and factors influencing inter-individual response.
Flavonoid
Mechanisms
Microbiome
Neurodegeneration
Nutritional psychiatry
Psychiatry
Journal
Free radical biology & medicine
ISSN: 1873-4596
Titre abrégé: Free Radic Biol Med
Pays: United States
ID NLM: 8709159
Informations de publication
Date de publication:
20 08 2021
20 08 2021
Historique:
received:
16
03
2021
revised:
14
05
2021
accepted:
26
05
2021
pubmed:
2
6
2021
medline:
20
8
2021
entrez:
1
6
2021
Statut:
ppublish
Résumé
The pathophysiology of psychiatric and neurodegenerative disorders is complex and multifactorial. Polyphenols possess a range of potentially beneficial mechanisms of action that relate to the implicated pathways in psychiatric and neurodegenerative disorders. The aim of this review is to highlight the emerging clinical trial and preclinical efficacy data regarding the role of polyphenols in mental and brain health, elucidate novel mechanisms of action including the gut microbiome and gene expression, and discuss the factors that may be responsible for the mixed clinical results; namely, the role of interindividual differences in treatment response and the potentially pro-oxidant effects of some polyphenols. Further clarification as part of larger, well conducted randomized controlled trials that incorporate precision medicine methods are required to inform clinical efficacy and optimal dosing regimens.
Identifiants
pubmed: 34062263
pii: S0891-5849(21)00347-6
doi: 10.1016/j.freeradbiomed.2021.05.036
pii:
doi:
Substances chimiques
Polyphenols
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
101-122Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.